As a strong analgesic for the relief of moderate to severe pain.
The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the...
Merck announced that the FDA has accepted for review the Biologics License Application (BLA) for MK-8237, Merck’s house dust mite...
AcelRx Pharmaceuticals announced the publication of a pooled analysis in the peer reviewed journal, Pain Management, analyzing the results of...